Molecular Vision 2014; 20:242-258
Received 19 June 2013 | Accepted 28 February 2014 | Published 03 March 2014
The first two authors contributed equally to the work.
1Department of Ophthalmology and Eye Hospital, University of Leipzig, Leipzig, Germany; 2Institute of Human Genetics, University of Regensburg, Regensburg, Germany; 3Paul Flechsig Institute of Brain Research, University of Leipzig, Leipzig, Germany; 4Helios Klinikum Aue, Aue, Germany
Correspondence to: Margrit Hollborn, Department of Ophthalmology and Eye Hospital, University of Leipzig, Faculty of Medicine, Liebigstrasse 10-14, D-04103 Leipzig, Germany; Phone : +49 (0) 341 97 21 561; FAX : +49(0) 341 97 21 659 ; email: firstname.lastname@example.org
Purpose: Vegetable polyphenols (bioflavonoids) have been suggested to represent promising drugs for treating cancer and retinal diseases. We compared the effects of various bioflavonoids (epigallocatechin-3-gallate [EGCG], luteolin, apigenin, myricetin, quercetin, and cyanidin) on the physiological properties and viability of cultured human retinal pigment epithelial (RPE) cells.
Methods: Human RPE cells were obtained from several donors within 48 h of death. Secretion of vascular endothelial growth factor (VEGF) was determined with enzyme-linked immunosorbent assay. Messenger ribonucleic acid levels were determined with real-time reverse transcription polymerase chain reaction. Cellular proliferation was investigated with a bromodeoxyuridine immunoassay, and chemotaxis was examined with a Boyden chamber assay. The number of viable cells was determined by Trypan Blue exclusion. Apoptosis and necrosis rates were determined with a DNA fragmentation enzyme-linked immunosorbent assay. The phosphorylation level of signaling proteins was revealed by western blotting.
Results: With the exception of EGCG, all flavonoids tested decreased dose-dependently the RPE cell proliferation, migration, and secretion of VEGF. EGCG inhibited the secretion of VEGF evoked by CoCl2-induced hypoxia. The gene expression of VEGF was reduced by myricetin at low concentrations and elevated at higher concentrations. Luteolin, apigenin, myricetin, and quercetin induced significant decreases in the cell viability at higher concentration, by triggering cellular necrosis. Cyanidin reduced the rate of RPE cell necrosis. Myricetin caused caspase-3 independent RPE cell necrosis mediated by free radical generation and activation of calpain and phospholipase A2. The myricetin- and quercetin-induced RPE cell necrosis was partially inhibited by necrostatin-1, a blocker of programmed necrosis. Most flavonoids tested diminished the phosphorylation levels of extracellular signal-regulated kinases 1/2 and Akt proteins.
Conclusions: The intake of luteolin, apigenin, myricetin, and quercetin as supplemental cancer therapy or in treating retinal diseases should be accompanied by careful monitoring of the retinal function. The possible beneficial effects of EGCG and cyanidin, which had little effect on RPE cell viability, in treating retinal diseases should be examined in further investigations.
Numerous studies performed in the last few years have shown that vegetable polyphenols (bioflavonoids) possess a wide range of activities in preventing common diseases including cancer, inflammation, infections, neovascularization, and neurodegenerative diseases [1-3]. Many dietary flavonoids have anti-inflammatory and antioxidant properties. For example, catechins of green tea, of which (-)-epigallocatechin-3-gallate (EGCG) is the most abundant, can inhibit tumorigenesis and angiogenesis in tumor tissues [4,5].
Enhanced production of free oxygen and nitrogen radicals contributes to the pathogenesis of important blinding diseases, including diabetic retinopathy, retinitis pigmentosa, and age-related macular degeneration [6-8]. Because bioflavonoids have anti-inflammatory and radical scavenging activities and suppress angiogenesis, they could have also potential benefits in inhibiting retinal diseases associated with oxidative stress, inflammation, and neovascularization. EGCG was shown to protect the retina from ischemic damage, mainly via its antioxidative activity [9,10]. Green tea, EGCG, and other flavonoids such as luteolin, myricetin, and quercetin, have also been shown to attenuate experimental retinal neovascularization, ischemic retinal injury, diabetic retinopathy, and light-induced photoreceptor apoptosis, respectively [11-16].
The mechanisms of the protective activities of flavonoids are not fully understood . Many bioflavonoids including green tea catechins were shown to have antioxidant activity at low concentrations and prooxidant activity at high concentrations [1,5,17]. Antioxidant and prooxidant effects were suggested to be implicated in the anti-inflammatory and anticancer activities of dietary flavonoids . The prooxidant effect appears to be responsible for inducing apoptosis in tumor cells and may also cause indirect antioxidant effects via induction of endogenous antioxidant systems in normal tissues that offer protection against oxidative stress . In addition, excessive intake of vegetable polyphenols, as dietary supplements or natural food, may have adverse effects, for example, by inhibiting prosurvival pathways. The cytotoxicity of dietary flavonoids is helpful in treating cancer, but may also concern non-transformed cells . We showed recently that curcumin (the yellow pigment of turmeric) at doses described to be effective in treating tumor cells has cytotoxic effects on human retinal pigment epithelial (RPE) cells and induces apoptosis and necrosis of the cells . In another study, the flavonoids resveratrol (from red wine) and curcumin were shown to cause RPE cell death by inducing apoptosis and necrosis .
RPE cells play crucial roles in protecting the outer retina from photooxidative stress, in digesting shed photoreceptor outer segments which contain oxidized lipids, and in inhibiting retinal edema and neovascularization . Dysfunction and degeneration of RPE cells are crucially involved in the pathogenesis of age-related macular degeneration [22,23]. The dry form of this blinding disease is characterized by the presence of lipofuscin within the RPE and drusen beneath the RPE, which contain photoreceptor-derived oxidized lipids, as well as by RPE cell death (geographic atrophy), while the hallmarks of the wet form are choroidal neovascularization and subretinal edema induced by outer retinal hypoxia [22,23]. Vascular endothelial growth factor (VEGF) is the main hypoxia-induced angiogenic factor that promotes retinal neovascularization and edema . RPE cells are one source of VEGF in the retina .
Intake of bioflavonoids, as dietary supplements or natural food, is suggested to be helpful as supplemental therapy of cancer and chronic inflammation, and in preventing retinal disorders. However, it has been also suggested that excessive intake of vegetable polyphenols may have adverse effects that concern not only tumor cells but also non-transformed cells . Therefore, further assessment for potential hazards of bioflavonoids should be considered before the compounds are used in the clinical setting . In the present study, we compared the effects of various flavonoids on the physiologic properties of cultured human RPE cells involved in cellular responses to pathogenic conditions (secretion of VEGF, cellular proliferation and migration) and on the viability of the cells. The following compounds were tested: EGCG from green tea, luteolin from parsley, apigenin from celery and parsley, myricetin from black tea, grapes, walnuts, etc., quercetin from bulbs, and cyanidin from various plants such as red cabbage, blueberries, and strawberries. We found that, although most of the flavonoids investigated inhibited the release of VEGF and the proliferation and migration of RPE cells at higher concentrations, the flavonoids had also deleterious effects on cell viability and induced cellular necrosis. Two compounds, EGCG and cyanidin, were had little effect on cell viability and, thus, are suggested as candidates for further examination as possible therapeutic agents in retinal diseases.
All tissue culture components and solutions were purchased from Gibco BRL (Paisley, UK). Human recombinant platelet-derived growth factor (PDGF)-BB was purchased from R&D Systems (Minneapolis, MN). Necrostatin-1, inactive necrostatin-1, 3-(4-iodophenyl)-2-mercapto-(Z)-2-propenoic acid (PD150606), 2'-amino-3′-methoxyflavone (PD98059), and anthra(1–9-cd)pyrazol-6(2H)-one (SP600125) were from Calbiochem (Bad Soden, Germany). The peptides Ac-DEVD-CHO (asp-glu-val-asp) and Ac-IETD-CHO (ile-glu-thr-asp) were from Enzo Life Science (Lörrach, Germany). 3,4-Dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinoline (DPQ) and all other compounds used were from Sigma-Aldrich (Taufkirchen, Germany), unless stated otherwise. The following antibodies were used: rabbit antiglyceraldehyde-3-phosphate dehydrogenase (GAPDH; New England Biolabs, Frankfurt/M., Germany; 1:2,000), rabbit antihuman extracellular signal-regulated kinases 1 and 2 (ERK1/2; New England Biolabs; 1:1,000), rabbit antiphosphorylated ERK1/2 (New England Biolabs; 1:1,000), rabbit antihuman p38 mitogen-activated protein kinase (MAPK; New England Biolabs; 1:1,000), rabbit antihuman phosphorylated p38 MAPK (New England Biolabs; 1:750), rabbit antihuman protein kinase B (Akt; New England Biolabs; 1:1,000), rabbit antihuman phosphorylated Akt (New England Biolabs; 1:1,000), and antirabbit immunoglobulin conjugated with alkaline phosphatase (Chemicon, Hofheim, Germany; 1:3,000).
The use of human material was approved by the Ethics Committee of the University of Leipzig and was performed according to the Declaration of Helsinki. Human RPE cells were obtained from several donors within 48 h of death, and were prepared and cultured as follows. After the vitreous and the retina were removed, the RPE cells were mechanically harvested, separated by digestion with 0.05% trypsin and 0.02% EDTA, and washed two times with PBS pH 7.2 (1.54 mM KH2PO4; 155.17 mM NaCl; 2.71 mM Na2HPO4x7H2O, Invitrogen, Paisley, UK). The cells were suspended in complete Ham F-10 medium containing 10% fetal bovine serum, GlutaMAX II, and penicillin/streptomycin, and were cultured in tissue culture flasks (Greiner, Nürtingen, Germany) in 95% air/5% CO2 at 37 °C. Cells of passages 3 to 5 were used. The epithelial nature of the RPE cells was routinely identified with immunocytochemistry using the monoclonal antibodies AE1 (recognizing most of the acidic type I keratins) and AE3 (recognizing most of the basic type II keratins), both from Chemicon. To test the substances, cultures that reached approximately 90% confluency were growth arrested in medium without serum for 5 h. Subsequently, media containing 0.5% serum with and without test substances were added.
The proliferation rate of RPE cells was determined by measuring the incorporation of bromodeoxyuridine (BrdU) into the genomic DNA. The cells were seeded at 3×103 cells per well in 96-well microtiter plates (Greiner), and were allowed to attach for 48 h. Thereafter, the cells were growth arrested in medium without serum for 5 h, and subsequently, medium containing 0.5% serum with and without test substances was added for another 24 h. BrdU incorporation was determined by using the Cell Proliferation Enzyme-linked Immunosorbent Assay (ELISA) BrdU Kit (Roche, Mannheim, Germany). BrdU (10 μM) was added to the culture medium 5 h before fixation.
Chemotaxis was determined with a modified Boyden chamber assay. Suspensions of RPE cells (100 µl; 5×105 cells/ml serum-free medium) were seeded onto polyethylene terephthalate filters (diameter 6.4 mm, pore size 8 µm; Becton Dickinson, Heidelberg, Germany) coated with fibronectin (50 µg/ml) and gelatin (0.5 mg/ml). Within 16 h after seeding, the cells attached to the filter and formed a semiconfluent monolayer. The cells were pretreated with blocking substances for 30 min, and thereafter, the medium was changed into medium without additives in the upper well and medium containing test substances in the lower well. After incubation for 6 h, the inserts were washed with buffered saline, fixed with Karnofsky’s reagent, and stained with hematoxylin. Non-migrated cells were removed from the filters by gentle scrubbing with a cotton swab. The migrated cells were counted, and the results were expressed relative to the cell migration rate in the absence of the test substances.
Cell viability was determined by Trypan Blue exclusion. The cells were seeded at 5×104 cells per well in six-well plates. After the cells reached 90% confluency, they were cultured in serum-free medium 16 h, and then stimulated with test substances for 6 and 24 h, respectively. After trypsinization, the cells were stained with Trypan Blue (0.4%), and the number of viable (non-stained) and dead (stained) cells were determined using a hemocytometer.
The Cellular DNA Fragmentation ELISA (Roche) was used to determine whether the cells undergo apoptosis or necrosis in the absence and presence of test substances. The cells were seeded at 3×103 cells per well in 96-well plates, and were cultured until confluency was reached. After the culture media were changed, the cells were prelabeled with BrdU for 16 h and then incubated in the absence or presence of the test substances in F-10/0.5% fetal calf serum for 6 and 24 h, respectively. Necrosis was determined by analyzing the BrdU-labeled DNA fragments in the cell-free culture supernatants, and apoptosis was determined by using the cytoplasmic lysates of the cells.
Total RNA was extracted from cultured cells by using the RNeasy Mini Kit (Qiagen, Hilden, Germany). The quality of the RNA was analyzed with agarose gel electrophoresis. The A260/A280 ratio of optical density was measured using the NanoDrop 1000 device (Peqlab, Erlangen, Germany), and was between 1.9 and 2.1 for all RNA samples, indicating sufficient quality.
After treatment with DNase I (Roche), cDNA was synthesized from 1 µg of total RNA using the RevertAid H Minus First Strand cDNA Synthesis Kit (Fermentas, St. Leon-Roth, Germany). For subsequent PCR amplification, the cDNA was diluted by addition of 20 µl RNase free water. Semiquantitative real-time reverse transcription (RT)–PCR was performed with the Single-Color Real-Time PCR Detection System (BioRad, Munich, Germany) using the following primer pairs: VEGFA (NM_001025370; 407, 347, and 275 bp), sense 5ʹ-CCT GGT GGA CAT CTT CCA GGA GTA-3ʹ, anti-sense 5ʹ-CTC ACC GCC TCG GCT TGT CAC A-3ʹ; ACTB (NM_001101; 237 bp), sense 5ʹ-ATG GCC ACG GCT GCT TCC AGC-3ʹ, anti-sense 5ʹ-CAT GGT GGT GCC GCC AGA CAG-3ʹ. The PCR solution contained 1 µl cDNA, a specific primer set (0.25 µM each), and 10 µl of iQ SYBR Green Supermix (BioRad) in a final volume of 20 µl. The following conditions were used: initial denaturation and enzyme activation (one cycle at 95 °C for 3 min); denaturation, amplification, and quantification, 45 cycles at 95 °C for 30 s, 58 °C for 20 s, and 72 °C for 45 s. This was followed by a melt curve analysis (81 cycles) to determine the product specificity where the temperature was gradually increased from 55 °C to 95 °C (0.5 °C/cycle). The amplified samples were analyzed with standard agarose gel electrophoresis. The mRNA expression was normalized to the level of ACTB expression. The changes in mRNA expression were calculated according to the 2-ΔΔCT method (CT, cycle threshold), with ΔCT=CTtarget gene - CTactb and ΔΔCT=ΔCTtreatment - ΔCTcontrol.
The cells were cultured at 3×103 cells per well in 96-well plates (100 µl culture medium per well). At approximately 90% confluency, the cells were cultured in serum-free medium for 16 h. Subsequently, the culture medium was changed, and the cells were stimulated with test substances. The supernatants were collected after 6 h, and the level of VEGF-A165 in the cultured media (200 µl) was determined with ELISA (R&D Systems) according to the manufacturer's recommendations.
The cells were seeded at 1×105 cells per well in six well plates in 1.5 ml complete medium, and were allowed to grow up to approximately 90% confluency. After growth arrest for 16 h, the cells were treated with test substances for 15 min. Then, the medium was removed, the cells were washed twice with prechilled PBS (pH 7.2; Invitrogen), and the monolayer was scraped into 150 µl lysis buffer (Mammalian Cell Lysis-1 Kit; Sigma). The total cell lysates were centrifuged at 10,000 × g for 10 min, and the supernatants were analyzed with immunoblots. Equal amounts of protein (30 µg) were separated by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis. Immunoblots were probed with primary and secondary antibodies, and immunoreactive bands were visualized using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium.
For each test, at least three independent experiments were performed in triplicate using cells from different donors. Data are expressed as means±standard error of the mean (SEM). Statistical analysis was performed with the Prism program (GraphPad Software, San Diego, CA). Significance was determined with one-way ANOVA followed by Bonferroni's multiple comparison test, and was accepted at p<0.05.
VEGF is a key player in choroidal neovascularization , and RPE cells are one source of VEGF in the retina . To determine whether bioflavonoids modulate the secretion of VEGF protein from RPE cells, we determined the level of VEGF-A165 in the cultured media with ELISA. The release of VEGF was examined under control conditions and after the cells were stimulated with PDGF and CoCl2-induced chemical hypoxia, respectively. PDGF and hypoxia are known inducers of VEGF secretion from RPE cells . As shown in Figure 1A, the major catechin of green tea, EGCG, did not alter the secretion of VEGF from RPE cells under control and PDGF-stimulated conditions when tested at concentrations between 1 and 50 µM. However, EGCG induced a dose-dependent decrease in the secretion of VEGF induced with chemical hypoxia. All other bioflavonoids tested, that is, luteolin (Figure 1B), apigenin (Figure 1C), myricetin (Figure 1D), quercetin (Figure 1E), and cyanidin (Figure 1F), induced dose-dependent decreases in the secretion of VEGF from RPE cells under all three conditions tested.
Myricetin induced a strong decrease in the secretion of VEGF protein from RPE cells (Figure 1D). To determine whether the compound also alters the expression of the VEGFA gene, we performed real-time RT–PCR. As shown in Figure 2A, myricetin induced a significant (p<0.05) decrease in the VEGFA expression at 10 µM, but a strong increase in VEGFA expression at 100 µM. Because the myricetin-induced increase in the gene expression of VEGF is reduced in the presence of an inhibitor of programmed necrosis, necrostatin-1 (Figure 2B), high concentrations of myricetin could induce cell stress, which is characterized by (among others) increased gene expression of VEGF.
RPE cell proliferation and migration are characteristic features of proliferative retinal diseases. To determine whether bioflavonoids alter physiologic characteristics of RPE cells, we measured the proliferation and chemotaxis of cultured cells in the absence and presence of PDGF, a known mitogen and motogen of the cells . As shown in Figure 3A, EGCG as the major green tea catechin did not significantly alter the proliferation rate of RPE cells under control and PDGF-stimulated conditions. Similarly, EGCG had no effect on the chemotaxis of RPE cells, under the control and PDGF-stimulated conditions (Figure 4A). All other bioflavonoids tested, that is, luteolin, apigenin, myricetin, quercetin, and cyanidin, induced dose-dependent decreases in the proliferation rate under control and PDGF-stimulated conditions (Figure 3B–F). Whereas the flavonoids (with the exception of EGCG) decreased dose-dependently the PDGF-induced chemotaxis of RPE cells (Figure 4B–F), the chemotaxis under non-stimulated control conditions was differently regulated by different flavonoids. Although apigenin and myricetin decreased the migration of the cells at the highest concentrations tested (Figure 4C, D), luteolin and quercetin induced increased chemotaxis of RPE cells under control conditions (Figure 4B, E), and cyanidin had no effect (Figure 4F).
To determine whether the inhibitory effects of the flavonoids on the secretion of VEGF and the proliferation and chemotaxis of RPE cells involve a toxic effect on the cells, we determined cell viability by staining with Trypan Blue and counting the living and dead cells. Whereas EGCG (Figure 5A) and cyanidin (Figure 5F) up to a concentration of 100 µM did not significantly decrease the viability of the cells, luteolin (Figure 5B), apigenin (Figure 5C), myricetin (Figure 5D), and quercetin (Figure 5E) induced significant (p<0.05) decreases in the cell viability at the higher concentrations tested. The data suggest that the effects of different flavonoids on the secretion of VEGF and the proliferation and chemotaxis of RPE cells are, at least at higher concentrations, mediated by toxic effects of the compounds. However, cyanidin decreased the secretion of VEGF without a significant reduction in the cell viability (Figure 6).
By measuring the internucleosomal DNA fragmentation rate in the cultured media and cell lysates, we determined whether the decrease in RPE cell viability induced by various flavonoids was mediated by induction of apoptosis and/or necrosis. An increased level of BrdU-labeled DNA fragments in the cell-free culture supernatants reflects cellular necrosis, while an increased level of BrdU-labeled DNA fragments in the cell lysates reflects apoptosis of the cells. Triton X-100 (1%) was used as the positive control. As previously described , Triton induced an increase in the DNA fragmentation rate in the RPE cell lysate after 6 and 24 h of stimulation, while the DNA fragmentation rate in the cultured media remained unchanged (Figure 7). The data suggest that Triton evoked apoptosis but not necrosis of RPE cells. The green tea catechin EGCG did not induce apoptosis or necrosis of RPE cells at both time periods investigated when tested at concentrations between 10 and 100 µM (Figure 7A). Luteolin (at 50 µM) induced significant (p<0.05) increases in the DNA fragmentation rates in the cell lysates and in the cultured media after 24 h of exposure (Figure 7B), suggesting that it induced apoptosis and necrosis of RPE cells. Apigenin (at 100 µM) induced necrosis but not apoptosis of RPE cells (Figure 7C). Myricetin did not induce apoptosis of RPE cells; however, it dose-dependently induced strong necrosis of the cells (Figure 7D). Similarly, quercetin induced dose-dependently necrosis of RPE cells, whereas it did not induce apoptosis (Figure 7E). Cyanidin did not induce apoptosis but decreased the rate of cellular necrosis after 6 h of exposure (Figure 7F).
Myricetin induced severe necrosis of RPE cells (Figure 7D). To determine the molecular mechanisms of myricetin-induced cytotoxicity, we evaluated the rate of DNA fragmentation in the cultured media in the presence of different caspase inhibitors. As shown in Figure 8A and B, the selective inhibitor of the effector caspase-3, DEVD, did not alter the rate of RPE cell necrosis induced by myricetin. The inhibitor of caspase-8, IETD, inhibited in part myricetin-induced RPE cell necrosis after 6 h (Figure 8A), but not after 24 h of stimulation (Figure 8B).
The lack of an effect of the caspase-3 inhibitor suggests that the myricetin-induced cytotoxicity is mediated by caspase 3-independent necrotic death pathways. An important activator of the caspase-independent cell death is the mitochondrial flavoprotein apoptosis-induced factor, which mediates chromatin condensation and DNA fragmentation when translocated to the nucleus . The release of the apoptosis-induced factor from the mitochondria can be triggered by different mechanisms, including activation of poly(ADP-ribose) polymerase-1 (PARP-1). To determine whether activation of this nuclear enzyme participates in myricetin-induced RPE cell death, we used the selective PARP-1 inhibitor DPQ. DPQ did not prevent RPE cell necrosis induced by myricetin (Figure 8A,B). Concomitant inhibition of PARP-1 and caspase-3 using DPQ plus DEVD did also not block myricetin-induced RPE cell death (not shown). Similarly, the inhibitor of the NADPH oxidase pathway and the uncoupling protein-2/mitochondrial pathway, perindopril, and the inhibitor of mitochondrial permeability transition, cyclosporin A, displayed no effects (Figure 8A,B). In addition, the mitochondrial KATP channel opener pinacidil had no effect (Figure 8A,B). The data suggest that activation of the mitochondrial apoptotic pathway is not involved in mediating the cytotoxic effect of myricetin.
Another mechanism that could contribute to the myricetin-induced cytotoxicity is activation of the cysteine protease calpain. Calpain activation has been recently implicated in the toxic effect of curcumin in RPE cells . Pretreatment of RPE cells with the calpain inhibitor PD150606 (which prevents the binding of calcium to calpain and does not significantly inhibit cathepsins and caspases ) fully abrogated the RPE cell necrosis induced by myricetin (Figure 8A,B). The data suggest that calpain activation is involved in mediating the toxic effect of myricetin. Activation of apoptotic pathways  and the excitotoxic death of oligodendrocytes  were shown to depend on the generation of reactive oxygen species. Preincubation of the cells with the cell-permeable dithiol-reducing agent dithiothreitol significantly (p<0.05) reduced the rate of RPE cell necrosis induced by myricetin (Figure 8A,B). The data suggest that generation of free oxygen radicals contributes to the myricetin-induced cytotoxicity. We found also that the inhibitor of phospholipase A2, 4-bromophenacyl bromide, reduced the cytotoxic effect of myricetin (Figure 8A,B). However, the cyclooxygenase inhibitor indomethacin had no effect (Figure 8A,B). Furthermore, inhibition of ERK1/2 activation with the specific MAPK kinase (MEK) antagonist PD98059 did not suppress the myricetin-induced DNA fragmentation (Figure 8A,B). Inhibition of c-Jun NH2-terminal kinase (JNK) activation by SP600125 reduced slightly the DNA fragmentation rate after 6 h (Figure 8A), but not after 24 h of myricetin stimulation (Figure 8B).
To determine whether the myricetin-induced cytotoxicity is mediated by programmed necrosis, we tested the inhibitor of necroptosis, necrostatin-1 . As shown in Figure 9A, necrostatin-1 decreased significantly (p<0.05) the myricetin-induced increase in the DNA fragmentation rate of the cultured media. However, the inactive derivative of necrostatin-1  had no effect (Figure 9A). We also found that the quercetin-induced increase in the DNA fragmentation rate of the cultured media is largely inhibited by necrostatin-1 (Figure 9B). The data suggest that the myricetin-induced RPE cell necrosis is mainly mediated by activation of death pathways that involve generating free oxygen radicals and activating calpain and phospholipase A2, as well as activating caspase-8 and JNK in the early phase of cell death. The myricetin-induced cytotoxicity is in part mediated by the induction of programmed necrosis.
We found that various bioflavonoids decrease the proliferation (Figure 3B–F), migration (Figure 4B–F), and viability of RPE cells (Figure 5B–E). Therefore, we determined with western blotting analysis whether the flavonoids alter the phosphorylation levels of three major ligand-induced signal transduction pathways. Activation of the Ras-Raf-ERK MAPK pathway is an important step in intracellular signaling that stimulates the proliferation of RPE cells [26,33]. Activation of p38 MAPK is implicated in stimulation of cellular migration , while activation of the phosphatidylinositol-3 kinase-Akt signaling pathway stimulates the protein synthesis at the translational level required for cell growth and survival . As shown in Figure 10A, the green tea catechin EGCG did not induce significant alterations in the phosphorylation levels of ERK1/2, p38 MAPK, and Akt in RPE cells when the cells were stimulated for 15 min and the compound was tested at concentrations between 1 and 50 µM. However, PDGF induced increases in the phosphorylation levels of the proteins (Figure 10A), as previously described . Luteolin (Figure 10B), apigenin (Figure 10C), myricetin (Figure 10D), quercetin (Figure 10E), and cyanidin (Figure 10F) induced decreases in the phosphorylation level of ERK1/2 at higher concentrations.
With the exception of cyanidin, the bioflavonoids tested did not alter the phosphorylation level of p38 MAPK in RPE cells (Figure 10A–E). Cyanidin decreased the phosphorylation level of p38 MAPK at higher doses (Figure 10F). With the exception of EGCG (Figure 10A), all flavonoids tested decreased dose-dependently the phosphorylation level of Akt protein (Figure 10B–F).
Vegetable polyphenols are suggested to represent promising drugs for the supplemental therapy of cancer in particular because of their capability to induce apoptosis in tumor cells [4,5]. Bioflavonoids may have also benefits in treating retinal diseases [12-16]. However, an excessive intake of bioflavonoids may have adverse effects that may concern non-transformed cells . In RPE cells, for example, curcumin and other flavonoids were shown to have cytotoxic effects and may induce apoptosis and necrosis [19,20]. Therefore, excess intake of bioflavonoids, either as supplemental cancer therapy or in the treatment of retinal diseases, may have adverse effects on the retina. In the present study, we compared the effects of various vegetable polyphenols in cultured human RPE cells. We found that the various flavonoids differentially affect the physiologic properties of RPE cells including the secretion of VEGF and cellular proliferation and migration, and that some of the compounds tested (luteolin, apigenin, myricetin, quercetin) decreased dose-dependently the viability of the cells (Figure 5) and induced apoptosis and/or necrosis (Figure 7). Overall, the effects of the compounds on the physiologic parameters were observed at concentrations lower than doses that induced a decrease in cell viability. However, the concentration windows between the beneficial and detrimental effects depended on the compound investigated and were larger in the case of apigenin and smaller in the case of myricetin, for example. We assume that the polyphenols tested at low concentrations have beneficial effects, as suggested by the VEGF-decreasing effect and the inhibition of cellular migration and proliferation, and at higher concentrations, the polyphenols (with the exception of EGCG and cyanidin) have toxic effects on the cells. However, further experiments are required to support this assumption.
EGCG and cyanidin did not significantly affect the viability of RPE cells (Figures 5A,F and Figure 6B) and did not induce apoptosis or necrosis (Figure 7A,F) at the concentrations tested. EGCG decreased the secretion of VEGF under conditions of chemical hypoxia, but not under control and PDGF-stimulated conditions (Figure 1A). EGCG did not prevent the proliferation and migration induced by PDGF (Figure 3A and Figure 4A). PDGF-induced cellular signaling is a major causative factor of proliferative retinopathies [35,36]. However, cyanidine inhibited the release of VEGF (Figure 1F and Figure 6A), the proliferation and migration of RPE cells (Figure 3F and Figure 4F), and the cellular necrosis (Figure 7F) without a significant reduction in the cell viability (Figure 5F and Figure 6B). The data suggest that EGCG and in particular cyanidin may have certain benefits to prevent RPE cell responses characteristically for neovascular and proliferative retinopathies.
Among the compounds tested, myricetin and quercetin induced strong increases in the rate of DNA fragmentation in the culture supernatants at relatively low concentrations (Figure 7D,E). Data obtained with pharmacological inhibitors (Figure 8A,B) suggest that the toxic effect of myricetin in RPE cells (Figure 5D) was mainly mediated by non-apoptotic death modes such as classical and/or programmed necrosis . Various indications suggest that activating apoptotic pathways did not significantly contribute to the toxic effect of myricetin in RPE cells: (1) We did not find any myricetin-induced increase in the DNA fragmentation rate in the cell lysates (Figure 7D). (2) The caspase-3 inhibitor DEVD did not prevent the myricetin-induced increase in the DNA fragmentation rate in the cultured media (Figure 8A,B). (3) The inhibitor of the mitochondrial permeability transition, cyclosporin A, had no effect on the myricetin-induced increase in the DNA fragmentation rate (Figure 8A,B). The independence of the myricetin-induced cell death from the mitochondrial apoptotic pathway is further suggested by the facts that the PARP-1 inhibitor DPQ, the inhibitor of the NADPH oxidase pathway and the uncoupling protein-2/mitochondrial pathway, perindopril, and the mitochondrial KATP channel opener pinacidil had no effects (Figure 8A,B). However, the contribution of distinct apoptotic pathways, at least of signaling steps upstream from the effector caspase-3, cannot be fully ruled out because the caspase-8 inhibitor IETD and the JNK inhibitor SP600125 decreased the DNA fragmentation rate in the culture supernatants after 6 h of stimulation with myricetin (Figure 8A). Prolonged activation of the stress-activated JNK was shown to be an important factor in apoptotic and necrotic cell death .
We found that the toxic effect of myricetin was mediated by induction of oxidative stress and activation of calpains and phospholipase A2 (Figure 8A,B). Reactive oxygen species are known to induce apoptosis and necrosis . They may contribute to JNK activation  which stimulates the mitochondrial production of superoxide , the main source of cellular oxidative stress involved in inducing necrosis . Increased levels of reactive oxygen species are known to activate calpains likely by increasing the intracellular free calcium level [39-41]. Sustained activation of calpain is known to trigger various intracellular signaling processes that lead to progressive plasma membrane damage, a hallmark of necrosis [42,43]. Activated calpains may also induce lysosome destabilization , at least in part by inducing mitochondrial permeability transition . However, because the inhibitor of mitochondrial permeability transition, cyclosporin A, did not prevent myricetin-induced RPE cell necrosis (Figure 8A,B), it seems to be unlikely that myricetin induces a rupture of lysosomes in RPE cells via this pathway. There are various necrotic pathways, including programmed necrosis, in which caspase-8 and calpains play a role . Caspase-8 is a subunit of the ripoptosome involved in inducing programmed necrosis [46,47]. We found that the inhibitor of programmed necrosis, necrostatin-1, decreased the myricetin- (Figure 9A) and quercetin- (Figure 9B) induced increase in the DNA fragmentation rate of the cultured media. Because necrostatin-1 does not block “classic” oxidative stress-induced necrosis , the data may suggest that the cytotoxicity induced by both compounds is in part mediated by inducing programmed necrosis. However, the contribution of various apoptotic and/or necrotic pathways to myricetin-induced RPE cell death remains to be better clarified in future experiments.
Further mechanisms may contribute to the induction of RPE cell necrosis by myricetin. By degrading the anchorage to the membrane cytoskeleton, activated calpains may impair the activity of the Na,K-ATPase . The activity of phospholipase A2 is increased in response to oxidative stress, resulting in lipid peroxidation and release of arachidonic acid . Arachidonic acid is a potent inhibitor of the Na,K-ATPase that leads to intracellular sodium overload, influx of water with consecutive cellular swelling, and possibly membrane rupture [50,51]. The inhibition of ERK1/2 and Akt activation (Figure 10B-F) may contribute to the decreases in RPE cell proliferation (Figure 3B-F) and survival (Figure 5B-E) induced by various flavonoids.
Because low concentrations of dietary flavonoids (up to 10 µM) did not decrease the viability of the cells (Figure 5) and did not induce significant apoptosis or necrosis (Figure 7), we assume that normal and moderate intake of the compounds as natural food will have no deleterious consequences in the RPE, and may have even beneficial effects, for example, in the cases of EGCG and cyanidin. Further experiments are required to compare the in vivo bioavailability and retinal effects of different vegetable polyphenols. However, it cannot be ruled out that increased intake of distinct flavonoids as dietary supplement in the (self-) therapy of cancer, for example, may have adverse effects on the retina resulting in dysregulation and degeneration of the RPE, in particular in subjects with decreased levels of antioxidant enzymes. To avoid accelerated development of age-related macular degeneration, which is characterized by dysfunction and degeneration of RPE cells, the intake of flavonoids at higher doses as supplemental cancer therapy or in the treatment of retinal diseases should be accompanied by careful monitoring of the retinal function. Possible beneficial effects of EGCG and cyanidin, which had little effects on the RPE cell viability in the concentration range investigated (Figure 5), in treating retinal diseases should be further examined.
The authors thank Ute Weinbrecht for excellent technical support. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 1547/7–1 to L.K; GRK 1097/1, RE 849/16–1, to A.R.) and the Geschwister Freter Stiftung (Hannover, Germany).